Logo

Eris Lifesciences Ltd. Share Price

Pharmaceuticals & Drugs

Eris Lifesciences Ltd. (INR)1383-17.5   (-1.2%)

Exchange ScripsBSE540596NSEERISISININE406M01024

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Eris Lifesciences Ltd. Performance

Market performance

Open price1384
High1403.6
Volumes41653
Prev Close1383
Low1372
Closing date2025-04-17

Historical performance

1 Year High1593.90
3 Year High1593.90
5 Year High1593.90
1 Year Low815.85
3 Year Low551.30
5 Year Low400.80

Eris Lifesciences Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
18871
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
47.99
Dividend Yield
Dividend Yield
N/A

Eris Lifesciences Ltd. Investment Returns

1 Year
59.5%
3 Years
96.9%
5 Years
184.3%
10 Years
N/A

Eris Lifesciences Ltd. Technicals

IndicatorsValueSignal
5-DMA1381.94Bullish
10-DMA1356.73Bullish
20-DMA1360.06Bullish
50-DMA1310.21Bullish
100-DMA1330.83Bullish
200-DMA1292.37Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters55555
Foreign Investors---------------
Domestic Investors55555
Public Investors5330946341441715174846491
Government1------------

Eris Lifesciences Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income23811226187
Operating Profit6986547951114395
Interest8482624220
Depreciation18261171647430
Profit Before Tax4312404644223945
Consolidated Net Profit3920382240613551
Adjusted EPS29283026

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital136136136136
Total Reserves25675217961892815589
Minority Interest6359247-1---
Total Non-Current Liabilities98787300-788-1091
Total Liabilities68188347192112717028
Capital Work in Progress191214240---
Total Assets68188347192112717028

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities4860291737833754
Cash Flow from Investing Activities-18545-9821-3196-3234
Cash Flow from Financing Activitie137986880-447-824
Net Cash Inflow / Outflow113-23140-304
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 47.99.
  • 3Y Stock Price CAGR of the stock is 26.3.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹6986 Million.
  • The company generated revenue of ₹20091 Million in the previous financial year.

Eris Lifesciences Ltd.

1383-17.5   (-1.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1568827.6
No. of Shares: 1134.4
Performance:56.9%
P/L: ₹568827.6

Top Gainers

SymbolChange%
SECMARK124.29(20%)
OSWALGREEN43.33(18%)
FACT760.85(14%)
OSWALAGRO96.73(13%)
SMSLIFE1435.2(13%)

Top Losers

SymbolChange%
VIKASLIFE2.59(-9%)
ROML50.49(-7%)
DYNPRO291(-6%)
ROSSELLIND77.66(-6%)
SONATSOFTW314.7(-6%)
TREJHARA232.28(-6%)
GATECHDVR1.05(-5%)
MGEL14.23(-5%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

65.8

56.06

March 20 - April 20

Brooks Laboratories Ltd.

41.3

139.77

March 20 - April 20

SMS Lifesciences India Ltd.

37.2

1435.2

March 20 - April 20

Panacea Biotec Ltd.

33.5

522.95

March 20 - April 20

Bal Pharma Ltd.

28.9

104.91

March 20 - April 20

Kopran Ltd.

27.8

202.58

March 20 - April 20

Wanbury Ltd.

27.2

263.47

March 20 - April 20

Hester Biosciences Ltd.

24.5

1774.9

March 20 - April 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month